• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

洋葱伯克霍尔德菌复合体临床分离株的血清药敏性:高通量基于生长的检测方法的建立。

Serum susceptibility in clinical isolates of Burkholderia cepacia complex bacteria: development of a growth-based assay for high throughput determination.

机构信息

Department of Pediatrics, Faculty of Medicine, Centre for Understanding and Preventing Infection in Children, University of British Columbia Vancouver, BC, Canada.

出版信息

Front Cell Infect Microbiol. 2012 May 28;2:67. doi: 10.3389/fcimb.2012.00067. eCollection 2012.

DOI:10.3389/fcimb.2012.00067
PMID:22919658
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3417400/
Abstract

Burkholderia cepacia complex (BCC) bacteria can cause devastating chronic infections in people with cystic fibrosis. Of particular concern is "cepacia syndrome," a rapidly progressive and usually fatal decline in health, characterized by a necrotizing bacteremic pneumonia. An important component of defense against bloodstream infections is the bactericidal action of serum. Traditional methods to determine the capacity of bacterial isolates to resist the bactericidal effects of serum are relatively low-throughput viability assays. In this study, we developed a novel growth-based assay for serum susceptibility, which allows for high throughput analysis. We applied this assay to a range of clinical isolates of BCC as well as isolates comprising the BCC experimental strain panel. Our data demonstrate that isolates from all species of BCC examined can possess serum resistant or serum sensitive/intermediate phenotypes. Of particular clinical significance, we also found no direct link between the last saved pulmonary isolate from patients who subsequently developed "cepacia syndrome" and their capacity to resist the inhibitory effects of human serum, suggesting serum resistance cannot be used as a marker of an isolate's capacity to escape from the lung and cause bacteremia.

摘要

洋葱伯克霍尔德菌复合群 (BCC) 细菌可引起囊性纤维化患者的破坏性慢性感染。特别令人关注的是“洋葱伯克霍尔德菌综合征”,这是一种迅速进展且通常致命的健康下降,其特征为坏死性菌血症性肺炎。抵抗血流感染的防御的一个重要组成部分是血清的杀菌作用。用于确定细菌分离株抵抗血清杀菌作用能力的传统方法是相对低通量的生存能力测定。在这项研究中,我们开发了一种新的基于生长的血清药敏测定法,可实现高通量分析。我们将该测定法应用于一系列临床分离株的 BCC 以及包含 BCC 实验菌株组的分离株。我们的数据表明,所检查的 BCC 所有种的分离株都可能具有血清抗性或血清敏感/中介表型。特别具有临床意义的是,我们还发现随后发生“洋葱伯克霍尔德菌综合征”的患者的最后保存的肺部分离株与它们抵抗人血清抑制作用的能力之间没有直接联系,这表明血清抗性不能用作分离株逃避肺部并引起菌血症的能力的标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22f2/3417400/b8be7681894c/fcimb-02-00067-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22f2/3417400/2274fbc65f94/fcimb-02-00067-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22f2/3417400/f89694f4cb7d/fcimb-02-00067-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22f2/3417400/b8be7681894c/fcimb-02-00067-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22f2/3417400/2274fbc65f94/fcimb-02-00067-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22f2/3417400/f89694f4cb7d/fcimb-02-00067-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22f2/3417400/b8be7681894c/fcimb-02-00067-g003.jpg

相似文献

1
Serum susceptibility in clinical isolates of Burkholderia cepacia complex bacteria: development of a growth-based assay for high throughput determination.洋葱伯克霍尔德菌复合体临床分离株的血清药敏性:高通量基于生长的检测方法的建立。
Front Cell Infect Microbiol. 2012 May 28;2:67. doi: 10.3389/fcimb.2012.00067. eCollection 2012.
2
Cloaking antibodies are prevalent in complex infection and their removal restores serum killing.隐匿抗体在复杂感染中很常见,清除它们可以恢复血清杀伤作用。
Front Cell Infect Microbiol. 2024 Aug 13;14:1426773. doi: 10.3389/fcimb.2024.1426773. eCollection 2024.
3
Prevalence of Burkholderia cepacia complex species in cystic fibrosis patients in Argentina during the period 2011-2015.2011年至2015年期间阿根廷囊性纤维化患者中洋葱伯克霍尔德菌复合体菌种的流行情况。
Enferm Infecc Microbiol Clin (Engl Ed). 2018 Aug-Sep;36(7):431-434. doi: 10.1016/j.eimc.2017.09.002. Epub 2017 Oct 18.
4
Evaluation of CHROMagar™ B. cepacia agar for the detection of Burkholderia cepacia complex species from sputum samples of patients with cystic fibrosis.评价 CHROMagar™ B. cepacia 琼脂对囊性纤维化患者痰液样本中洋葱伯克霍尔德菌复合群种属的检测。
Eur J Clin Microbiol Infect Dis. 2024 Jul;43(7):1349-1353. doi: 10.1007/s10096-024-04845-4. Epub 2024 May 23.
5
Burkholderia cepacia complex infections: More complex than the bacterium name suggest.伯克霍尔德菌复合体感染:比细菌名称所暗示的更为复杂。
J Infect. 2018 Sep;77(3):166-170. doi: 10.1016/j.jinf.2018.07.006. Epub 2018 Jul 24.
6
Antibiotic treatment for Burkholderia cepacia complex in people with cystic fibrosis experiencing a pulmonary exacerbation.囊性纤维化患者肺部病情加重时针对洋葱伯克霍尔德菌复合群的抗生素治疗
Cochrane Database Syst Rev. 2012 Oct 17;10:CD009529. doi: 10.1002/14651858.CD009529.pub2.
7
Clinical characteristics and outcomes of non-cystic fibrosis patients with Burkholderia cepacia complex bacteremia at a medical center in Taiwan.台湾某医学中心非囊性纤维化洋葱伯克霍尔德菌复合体菌血症患者的临床特征与转归
J Microbiol Immunol Infect. 2022 Dec;55(6 Pt 2):1301-1309. doi: 10.1016/j.jmii.2021.09.009. Epub 2021 Oct 8.
8
Approaches to measure the fitness of Burkholderia cepacia complex isolates.测量洋葱伯克霍尔德氏菌复合体分离株适应性的方法。
J Med Microbiol. 2010 Jun;59(Pt 6):679-686. doi: 10.1099/jmm.0.017830-0. Epub 2010 Feb 25.
9
Infection with Burkholderia cepacia complex bacteria and pulmonary exacerbations of cystic fibrosis.洋葱伯克霍尔德菌复合体细菌感染与囊性纤维化的肺部加重
Chest. 2007 Apr;131(4):1188-96. doi: 10.1378/chest.06-2611.
10
Incidence of Burkholderia contaminans at a cystic fibrosis centre with an unusually high representation of Burkholderia cepacia during 15 years of epidemiological surveillance.在一个囊性纤维化中心,在15年的流行病学监测期间,洋葱伯克霍尔德菌占比异常高的情况下,污染伯克霍尔德菌的发病率。
J Med Microbiol. 2015 Aug;64(8):927-935. doi: 10.1099/jmm.0.000094. Epub 2015 May 22.

引用本文的文献

1
Cyclic di AMP phosphodiesterase nanovaccine elicits protective immunity against Burkholderia cenocepacia infection in mice.环二磷酸腺苷磷酸二酯酶纳米疫苗可引发小鼠对洋葱伯克霍尔德菌感染的保护性免疫。
NPJ Vaccines. 2025 Feb 1;10(1):22. doi: 10.1038/s41541-025-01074-4.
2
Cloaking antibodies are prevalent in complex infection and their removal restores serum killing.隐匿抗体在复杂感染中很常见,清除它们可以恢复血清杀伤作用。
Front Cell Infect Microbiol. 2024 Aug 13;14:1426773. doi: 10.3389/fcimb.2024.1426773. eCollection 2024.
3
Recurrent spontaneous meningitis in an adult: a case report.

本文引用的文献

1
Rapid and quantitative automated measurement of bacteriophage activity against cystic fibrosis isolates of Pseudomonas aeruginosa.快速定量自动化测量噬菌体对铜绿假单胞菌囊性纤维化分离株的活性。
J Appl Microbiol. 2011 Mar;110(3):631-40. doi: 10.1111/j.1365-2672.2010.04928.x. Epub 2011 Jan 12.
2
"Cepacia syndrome" associated with Burkholderia cepacia (Genomovar I) infection in an adolescent with cystic fibrosis.一名患有囊性纤维化的青少年中与洋葱伯克霍尔德菌(基因变种I)感染相关的“洋葱伯克霍尔德菌综合征”
Pediatr Pulmonol. 2011 May;46(5):512-4. doi: 10.1002/ppul.21404. Epub 2010 Dec 30.
3
Lung transplantation for patients with cystic fibrosis and Burkholderia cepacia complex infection: a single-center experience.
一名成人复发性自发性脑膜炎:病例报告
JAC Antimicrob Resist. 2023 Mar 28;5(2):dlad029. doi: 10.1093/jacamr/dlad029. eCollection 2023 Apr.
4
Interactions Between Pathogenic and the Complement System: A Review of Potential Immune Evasion Mechanisms.病原体与补体系统的相互作用:潜在免疫逃避机制的综述。
Front Cell Infect Microbiol. 2021 Sep 30;11:701362. doi: 10.3389/fcimb.2021.701362. eCollection 2021.
5
Insertion sequences drive the emergence of a highly adapted human pathogen.插入序列推动了一种高度适应人类的病原体的出现。
Microb Genom. 2020 Sep;6(9). doi: 10.1099/mgen.0.000265. Epub 2019 Apr 4.
6
The Mla Pathway Plays an Essential Role in the Intrinsic Resistance of Burkholderia cepacia Complex Species to Antimicrobials and Host Innate Components.Mla 通路在伯克霍尔德氏菌复合体物种对抗微生物药物和宿主固有成分的固有抗性中发挥重要作用。
J Bacteriol. 2018 Aug 24;200(18). doi: 10.1128/JB.00156-18. Print 2018 Sep 15.
肺移植治疗囊性纤维化合并伯克霍尔德菌复合体感染患者:单中心经验。
J Heart Lung Transplant. 2010 Dec;29(12):1395-404. doi: 10.1016/j.healun.2010.06.007. Epub 2010 Sep 1.
4
Mucoid and nonmucoid Burkholderia cepacia complex bacteria in cystic fibrosis infections.黏液型和非黏液型洋葱伯克霍尔德菌复合群细菌在囊性纤维化感染中的作用。
Am J Respir Crit Care Med. 2011 Jan 1;183(1):67-72. doi: 10.1164/rccm.201002-0203OC. Epub 2010 Aug 13.
5
Isolation and characterisation of the biological repeating unit of cepacian, the exopolysaccharide produced by bacteria of the Burkholderia cepacia complex.分离和表征伯克霍尔德氏菌复合群细菌产生的胞外多糖 cepacian 的生物重复单元。
Carbohydr Res. 2010 Jul 2;345(10):1455-60. doi: 10.1016/j.carres.2010.03.029. Epub 2010 Mar 30.
6
Mechanisms in Neisseria meningitidis for resistance against complement-mediated killing.脑膜炎奈瑟菌抵抗补体介导杀伤的机制。
Vaccine. 2008 Dec 30;26 Suppl 8(6):I34-9. doi: 10.1016/j.vaccine.2008.11.059.
7
Survival after lung transplantation of cystic fibrosis patients infected with Burkholderia cepacia complex.感染洋葱伯克霍尔德菌复合体的囊性纤维化患者肺移植后的生存情况。
Am J Transplant. 2008 May;8(5):1025-30. doi: 10.1111/j.1600-6143.2008.02186.x. Epub 2008 Mar 3.
8
Differential mucoid exopolysaccharide production by members of the Burkholderia cepacia complex.洋葱伯克霍尔德菌复合体成员间不同的黏液样胞外多糖产生情况。
J Clin Microbiol. 2008 Apr;46(4):1470-3. doi: 10.1128/JCM.02273-07. Epub 2008 Feb 6.
9
Burkholderia cepacia complex bacteria: opportunistic pathogens with important natural biology.洋葱伯克霍尔德菌复合体细菌:具有重要自然生物学特性的机会致病菌
J Appl Microbiol. 2008 Jun;104(6):1539-51. doi: 10.1111/j.1365-2672.2007.03706.x. Epub 2008 Jan 24.
10
Pseudomonas aeruginosa and Burkholderia cenocepacia infections in patients affected by cystic fibrosis: serum resistance and antibody response.囊性纤维化患者中的铜绿假单胞菌和洋葱伯克霍尔德菌感染:血清抗性和抗体反应
Immunol Invest. 2008;37(1):19-27. doi: 10.1080/08820130701741775.